TMCI - TREACE MEDICAL CONCEPTS, INC.
IEX Last Trade
6.93
0.020 0.289%
Share volume: 6,848
Last Updated: Fri 27 Dec 2024 08:30:19 PM CET
Surgical and Medical Instrument Manufacturing :
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$6.91
0.02
0.29%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-10 | 2022-11-09 | 2023-03-08 | 2023-05-09 | 2023-08-09 | 2023-11-09 | 2024-02-27 | 2024-05-07 | |
| Total revenue | 29.967 M | 33.055 M | 49.769 M | 42.195 M | 41.953 M | 40.758 M | 62.212 M | 51.108 M | |
| Cost of revenue | 5.651 M | 6.624 M | 9.742 M | 8.039 M | 7.675 M | 7.998 M | 11.469 M | 10.127 M | |
| Gross profit | 24.316 M | 26.431 M | 40.027 M | 34.156 M | 34.278 M | 32.760 M | 50.743 M | 40.981 M | |
| 8.70% | 51.44% | -14.67% | 0.36% | -4.43% | 54.89% | -19.24% | |||
| Operating expenses | 36.249 M | 37.749 M | 43.524 M | 47.932 M | 47.330 M | 50.578 M | 57.525 M | 59.949 M | |
| Selling general and admin | 33.265 M | 33.950 M | 39.775 M | 44.520 M | 43.804 M | 46.228 M | 53.373 M | 54.690 M | |
| Research and development | 2.984 M | 3.799 M | 3.749 M | 3.412 M | 3.526 M | 4.350 M | 4.152 M | 5.259 M | |
| Total expenses | 41.900 M | 44.373 M | 53.266 M | 55.971 M | 55.005 M | 58.576 M | 68.994 M | 70.076 M | |
| 5.90% | 20.04% | 5.08% | -1.73% | 6.49% | 17.79% | 1.57% | |||
| Operating income | -11.933 M | -11.318 M | -3.497 M | -13.776 M | -13.052 M | -17.818 M | -6.782 M | -18.968 M | |
| Ebit | -11.933 M | -11.318 M | -3.497 M | -13.776 M | -13.052 M | -17.818 M | -6.782 M | -18.968 M | |
| Pretax income | -17.234 M | -12.133 M | -4.412 M | -13.454 M | -12.271 M | -17.521 M | -6.281 M | -18.676 M | |
| -29.60% | -63.64% | 204.94% | -8.79% | 42.78% | -64.15% | 197.34% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -17.234 M | -12.133 M | -4.412 M | -13.454 M | -12.271 M | -17.521 M | -6.281 M | -18.676 M | |
| 29.60% | 63.64% | -204.94% | 8.79% | -42.78% | 64.15% | -197.34% | |||
| Net income | -17.234 M | -12.133 M | -4.412 M | -13.454 M | -12.271 M | -17.521 M | -6.281 M | -18.676 M | |
| 29.60% | 63.64% | -204.94% | 8.79% | -42.78% | 64.15% | -197.34% |